QUAVONLIMAB vs REGORAFENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
QUAVONLIMAB vs REGORAFENIB: Safety Overview
| Metric | QUAVONLIMAB | REGORAFENIB |
|---|---|---|
| Total FAERS Reports | 368 | 9,441 |
| Deaths Reported | 23 | 1,869 |
| Death Rate | 6.3% | 19.8% |
| Hospitalizations | 346 | 3,363 |
| Average Patient Age | 63.7 yrs | 62.2 yrs |
| % Female Patients | 20.2% | 39.9% |
| FDA Approval Date | N/A | Jan 13, 2025 |
| Manufacturer | N/A | Bayer HealthCare Pharmaceuticals Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |